BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34131069)

  • 1.
    Conroy LR; Stanback AE; Young LEA; Clarke HA; Austin GL; Liu J; Allison DB; Sun RC
    Mol Cancer Res; 2021 Oct; 19(10):1727-1738. PubMed ID: 34131069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
    Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
    Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered N-linked glycosylation in endometrial cancer.
    Mittal P; Briggs M; Klingler-Hoffmann M; Kaur G; Packer NH; Oehler MK; Hoffmann P
    Anal Bioanal Chem; 2021 Apr; 413(10):2721-2733. PubMed ID: 33222001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
    Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
    Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
    Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
    Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential
    Yaman ME; Kayili HM; Albayrak M; Kadioglu Y; Salih B
    Mol Omics; 2021 Jun; 17(3):394-404. PubMed ID: 33735360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.
    Drake RR; Powers TW; Jones EE; Bruner E; Mehta AS; Angel PM
    Adv Cancer Res; 2017; 134():85-116. PubMed ID: 28110657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of N-linked glycans from formalin-fixed paraffin-embedded tissue sections using MALDI mass spectrometry.
    Toghi Eshghi S; Yang S; Wang X; Shah P; Li X; Zhang H
    ACS Chem Biol; 2014 Sep; 9(9):2149-56. PubMed ID: 25029481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines.
    de Leoz ML; An HJ; Kronewitter S; Kim J; Beecroft S; Vinall R; Miyamoto S; de Vere White R; Lam KS; Lebrilla C
    Dis Markers; 2008; 25(4-5):243-58. PubMed ID: 19126968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
    McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
    Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and functional analysis of the sialyl-T antigen in prostate cancer.
    Bai R; Luan X; Zhang Y; Robbe-Masselot C; Brockhausen I; Gao Y
    Glycoconj J; 2020 Aug; 37(4):423-433. PubMed ID: 32583304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.
    Nyalwidhe JO; Betesh LR; Powers TW; Jones EE; White KY; Burch TC; Brooks J; Watson MT; Lance RS; Troyer DA; Semmes OJ; Mehta A; Drake RR
    Proteomics Clin Appl; 2013 Oct; 7(9-10):677-89. PubMed ID: 23775902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.
    Briggs MT; Condina MR; Ho YY; Everest-Dass AV; Mittal P; Kaur G; Oehler MK; Packer NH; Hoffmann P
    Proteomics; 2019 Nov; 19(21-22):e1800482. PubMed ID: 31364262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometry Imaging of N-Glycans from Formalin-Fixed Paraffin-Embedded Tissue Sections Using a Novel Subatmospheric Pressure Ionization Source.
    Shi Y; Li Z; Felder MA; Yu Q; Shi X; Peng Y; Cao Q; Wang B; Puglielli L; Patankar MS; Li L
    Anal Chem; 2019 Oct; 91(20):12942-12947. PubMed ID: 31507162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays.
    Powers TW; Neely BA; Shao Y; Tang H; Troyer DA; Mehta AS; Haab BB; Drake RR
    PLoS One; 2014; 9(9):e106255. PubMed ID: 25184632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation status of serum immunoglobulin G in patients with prostate diseases.
    Kazuno S; Furukawa J; Shinohara Y; Murayama K; Fujime M; Ueno T; Fujimura T
    Cancer Med; 2016 Jun; 5(6):1137-46. PubMed ID: 26880719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues.
    Scott DA; Casadonte R; Cardinali B; Spruill L; Mehta AS; Carli F; Simone N; Kriegsmann M; Del Mastro L; Kriegsmann J; Drake RR
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800014. PubMed ID: 30592377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.
    Ishibashi Y; Tobisawa Y; Hatakeyama S; Ohashi T; Tanaka M; Narita S; Koie T; Habuchi T; Nishimura S; Ohyama C; Yoneyama T
    Prostate; 2014 Nov; 74(15):1521-9. PubMed ID: 25154914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
    Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer.
    Goto T; Terada N; Inoue T; Kobayashi T; Nakayama K; Okada Y; Yoshikawa T; Miyazaki Y; Uegaki M; Utsunomiya N; Makino Y; Sumiyoshi S; Yamasaki T; Kamba T; Ogawa O
    Prostate; 2015 Dec; 75(16):1821-30. PubMed ID: 26332786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.